| Post | Subject | | |
#161569
|
In addition, Astellas will no longer fund future
|
jq1234
| 05/23/13 05:22:29 PM |
|
#161568
|
MRK drops Preladenant program in Parkinson’s disease after
|
DewDiligence
| 05/23/13 05:13:29 PM |
|
#161555
|
Novo Nordisk reports 8% weight loss in phase
|
jbog
| 05/23/13 12:13:37 PM |
|
#161552
|
LPTN - ASONEP Trial to Study Effects of
|
CynicalTrader
| 05/23/13 10:41:23 AM |
|
#161506
|
The S-4 for the PFE-ZTS swap has been filed:
|
DewDiligence
| 05/22/13 01:04:59 PM |
|
#161479
|
PTLA IPOs at $14.50/share (the midpoint of anticipated range):
|
DewDiligence
| 05/22/13 09:01:52 AM |
|
#161626
|
PFE-ZTS addendum: Anyone who owns ZTS and is
|
DewDiligence
| 05/24/13 03:38:27 PM |
|
#161623
|
Ipso facto, you must now be using Twitter
|
DewDiligence
| 05/24/13 02:27:53 PM |
|
#161622
|
Did you catch the bogus Xarelto vs
|
genisi
| 05/24/13 02:17:18 PM |
|
#161621
|
[OT]—Comical Q&A on PG’s leadership change that was
|
DewDiligence
| 05/24/13 02:16:52 PM |
|
#161620
|
Right on schedule, two months from the CHMP approval.
|
DewDiligence
| 05/24/13 02:07:55 PM |
|
#161619
|
Xarelto® (rivaroxaban) has been approved by the European
|
genisi
| 05/24/13 02:00:50 PM |
|
#161617
|
another response about science of bavituximab
|
honestabe13
| 05/24/13 01:26:18 PM |
|
#161616
|
vinmantoo..see bavituximab argument response below..comments?
|
honestabe13
| 05/24/13 12:18:22 PM |
|
#161615
|
OGX-011 is a second-generation phosphorothioate antisense
|
Summer2762
| 05/24/13 11:45:12 AM |
|
#161614
|
Potential “universal” influenza vaccine developed and tested at FDA
|
CynicalTrader
| 05/24/13 10:59:57 AM |
|
#161613
|
Good article covering resistance in NSCLC from ASCO...
|
ariadndndough
| 05/24/13 10:42:27 AM |
|
#161612
|
MACK -Merrimack completes patient enrollment in Phase 2
|
CynicalTrader
| 05/24/13 10:16:46 AM |
|
#161611
|
So how does OGX-011 block the production of clusterin?
|
acgood
| 05/24/13 08:41:41 AM |
|
#161610
|
vin... thank you for your responsible response.
|
honestabe13
| 05/24/13 08:08:24 AM |
|
#161609
|
Astellas (ALPMY.PK) and Medivation (MDVN) say a marketing
|
dav1234
| 05/24/13 08:01:29 AM |
|
#161608
|
Elan (ELN) intends to issue $850M worth of
|
dav1234
| 05/24/13 07:56:12 AM |
|
#161607
|
Pfizer's (PFE) price target is hiked a buck
|
dav1234
| 05/24/13 07:54:28 AM |
|
#161606
|
Covidien's (COV) pharmaceuticals business, which it's spinning off
|
dav1234
| 05/24/13 07:53:32 AM |
|
#161605
|
The California Institute for Regenerative Medicine grants Sangamo
|
dav1234
| 05/24/13 07:50:01 AM |
|
#161604
|
Thanks very much for your input.
|
Malyshek
| 05/24/13 06:06:53 AM |
|
#161603
|
{{Loe says this asset is often overshadowed by
|
vinmantoo
| 05/24/13 12:57:10 AM |
|
#161602
|
Abe, jq1234 and others are correct that the
|
vinmantoo
| 05/24/13 12:54:59 AM |
|
#161601
|
the 'drug' does not claim to act on
|
iandy
| 05/23/13 10:56:22 PM |
|
#161598
|
$30 price target on OGXI.
|
Double_Bagel
| 05/23/13 10:38:34 PM |
|
#161595
|
MM-398 PII results...
|
CynicalTrader
| 05/23/13 10:13:35 PM |
|
#161594
|
Are you a MRK fan now?Yes, since the
|
DewDiligence
| 05/23/13 10:10:40 PM |
|
#161593
|
>>staving off macular degeneration
|
biomaven0
| 05/23/13 09:59:11 PM |
|
#161592
|
Also, there was also another OGXI related PR yesterday.
|
Summer2762
| 05/23/13 09:28:15 PM |
|
#161591
|
Re: OGXI
|
Summer2762
| 05/23/13 09:24:46 PM |
|
#161590
|
AVEOThe biomarker trials are a long shot.What do
|
mcbio
| 05/23/13 08:49:00 PM |
|
#161589
|
You wanted comments on the article. The main
|
jq1234
| 05/23/13 08:47:55 PM |
|
#161588
|
Abe, on CNBC today a panelist on a
|
north40000
| 05/23/13 08:27:18 PM |
|
#161587
|
jg where did i say it was
|
honestabe13
| 05/23/13 08:17:01 PM |
|
#161586
|
The biomarker trials are a long shot.
|
NP1986
| 05/23/13 08:13:06 PM |
|
#161585
|
Sure, I am not qualified. Did you even
|
jq1234
| 05/23/13 08:07:26 PM |
|
#161584
|
more bias with no scientific support.
|
honestabe13
| 05/23/13 07:59:17 PM |
|
#161583
|
Of course I was speaking of the Melanoma
|
Checkpoint
| 05/23/13 07:52:59 PM |
|
#161582
|
I agree Merck's Anti PD1 results are very
|
Checkpoint
| 05/23/13 07:49:04 PM |
|
#161581
|
jg... you did not address the science.
|
honestabe13
| 05/23/13 07:49:03 PM |
|
#161580
|
AVEOI am not entirely surprised. 1st line RCC
|
mcbio
| 05/23/13 07:42:35 PM |
|
#161579
|
I am not entirely surprised. 1st line RCC
|
jq1234
| 05/23/13 07:32:39 PM |
|
#161578
|
If someone cannot tell the article is a
|
jq1234
| 05/23/13 07:22:14 PM |
|
#161577
|
Medivir - positive Phase 1a data for MIV-711
|
mcbio
| 05/23/13 07:11:16 PM |
|
#161576
|
Somehow I think anorexia/cachexia is not as big
|
pcrutch
| 05/23/13 07:00:11 PM |
|
#161575
|
AVEOIn addition, Astellas will no longer fund future
|
mcbio
| 05/23/13 06:41:56 PM |
|
#161574
|
Maybe they should beef up there pipeline of
|
Checkpoint
| 05/23/13 06:39:32 PM |
|
#161573
|
unbelieveble that 80 million dollars a year is
|
drbio45
| 05/23/13 06:36:35 PM |
|
#161572
|
Crutch, Dew, Iwfal, vin, Ex, etc...
|
honestabe13
| 05/23/13 06:30:25 PM |
|
#161571
|
Are you a MRK fan now? Since I
|
jq1234
| 05/23/13 06:00:28 PM |
|
#161570
|
I suspect consensus estimates for Lambrolizumab (anti-PD-1) are
|
pcrutch
| 05/23/13 05:50:17 PM |
| Post | Subject | | |
